PFL
2,6-BIS(1-METHYLETHYL)PHENOL
Find entries where: PFL
is present as a standalone ligand in 11 entries
Chemical Component Summary | |
---|---|
Name | 2,6-BIS(1-METHYLETHYL)PHENOL |
Synonyms | 2,6-DIISOPROPYLPHENOL; PROPOFOL |
Identifiers | 2,6-di(propan-2-yl)phenol |
Formula | C12 H18 O |
Molecular Weight | 178.271 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)c1cccc(c1O)C(C)C |
InChI | InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 |
InChIKey | OLBCVFGFOZPWHH-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 0 |
Bond Count | 31 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB00818 |
---|---|
Name | Propofol |
Groups |
|
Description | Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries. |
Synonyms |
|
Brand Names |
|
Indication | Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus. |
Categories |
|
ATC-Code | N01AX10 |
CAS number | 2078-54-8 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Gamma-aminobutyric acid receptor subunit beta-2 | MWRVRKRGYFGIWSFPLIIAAVCAQSVNDPSNMSLVKETVDRLLKGYDIR... | unknown | potentiator |
Gamma-aminobutyric acid receptor subunit beta-3 | MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDI... | unknown | potentiator |
GABA(A) Receptor | MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL... | unknown | positive allosteric modulator |
Sodium channel protein type 4 subunit alpha | MARPSLCTLVPLGPECLRPFTRESLAAIEQRAVEEEARLQRNKQMEIEEP... | unknown | inhibitor |
Sodium channel protein type 2 subunit alpha | MAQSVLVPPGPDSFRFFTRESLAAIEQRIAEEKAKRPKQERKDEDDENGP... | unknown | inhibitor |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL526 |
PubChem | 4943 |
ChEMBL | CHEMBL526 |
ChEBI | CHEBI:44915 |
CCDC/CSD | ICEYEV, OXICUV02, EWIKAY, XOJYEC02, GAPTOG01, XOJYEC, GAPTOG, XOJYEC01, EWIJUR, MENXAI |
COD | 4510269, 4510267, 4510268 |